RESUMO
AIM: The prevalence of type 2 diabetes in young adults is increasing, yet little is known about medication use in this population. This study aimed to describe hypoglycaemic and cardiovascular treatment patterns in young adults newly treated with oral hypoglycaemic agents. METHODS: A retrospective cohort study from 2008-2011 was conducted using the Irish national pharmacy claims database. Subjects aged 15-39 years were analysed for use of hypoglycaemic therapy, subsequent regimen changes, and any co-prescription of cardiovascular agents 1 year after treatment initiation. Cox-proportional-hazards regression and logistic regression were used to examine factors associated with non-persistence to initial hypoglycaemic therapy (in males only), insulin use as a regimen change, and use of cardiovascular agents. Hazard ratios (HR), odds ratios (OR), and 95 % confidence intervals (CI) are presented. RESULTS: There were 5284 individuals initiated on hypoglycaemic agents. Most were initiated on metformin (88 %); 13 % of subjects received a hypoglycaemic agent regimen change, with insulin being used in 26 % of these cases. A total of 38 % of males were non-persistent with their initial hypoglycaemic agent, with males aged 15-29 years and those on sulphonylureas significantly more likely to be non-persistent with therapy. Over 40 % of subjects were initiated on cardiovascular agents. Females were less likely to receive cardiovascular agents [OR 0.50 (95 % CI 0.42-0.83)]. CONCLUSIONS: Treatment patterns were found to be associated with high levels of non-persistence, substantial use of insulin, and a low use of cardiovascular agents. This may pose problems for the management of the long-term complications associated with type 2 diabetes.
Assuntos
Fármacos Cardiovasculares/uso terapêutico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Hipoglicemiantes/uso terapêutico , Atenção Primária à Saúde , Adolescente , Adulto , Estudos de Coortes , Feminino , Humanos , Insulina/uso terapêutico , Modelos Logísticos , Masculino , Metformina/uso terapêutico , Razão de Chances , Modelos de Riscos Proporcionais , Estudos Retrospectivos , Compostos de Sulfonilureia/uso terapêutico , Adulto JovemRESUMO
AIM: To evaluate rectal hydrocortisone as an emergency glucocorticoid replacement therapy in adrenal insufficient children. METHODS: A parental questionnaire evaluated preferred treatment, problems or benefits of i.m. and rectal hydrocortisone, frequency and indications for administration and who administered treatment. Admissions of children with adrenal insufficiency were monitored. RESULTS: There were 39/52 families who responded to the questionnaire. 93% (26/28) preferred rectal hydrocortisone. Parents or children who previously received emergency treatment from a doctor now self-administered rectal hydrocortisone. The cost of suppositories and i.m. hydrocortisone is similar; however, storage of suppositories was inconvenient. One girl presented with pneumonia and collapse despite rectal hydrocortisone and a hydrocortisone level at admission of >2000 nmol/l with normal electrolytes. CONCLUSIONS: Rectal hydrocortisone is an acceptable and safe emergency therapy. We still advise i.m. hydrocortisone if rectal administration is not possible or with suppository extrusion.
Assuntos
Administração Retal , Insuficiência Adrenal/tratamento farmacológico , Hidrocortisona/administração & dosagem , Vômito/tratamento farmacológico , Adolescente , Insuficiência Adrenal/complicações , Insuficiência Adrenal/diagnóstico , Criança , Pré-Escolar , Feminino , Terapia de Reposição Hormonal/métodos , Humanos , Hidrocortisona/sangue , Hidrocortisona/farmacocinética , Lactente , Injeções Intramusculares/economia , Masculino , Cooperação do Paciente , Supositórios/economia , Supositórios/farmacocinética , Inquéritos e Questionários , Fatores de Tempo , Vômito/complicaçõesRESUMO
A cross-sectional study measuring head circumference was performed on 3,344 Irish Children aged from 5 to 19 years. Comparison with other countries showed a slightly larger head circumference than the 1965 British standards produced by Tanner, but significantly smaller than the Ounsted data from Oxford. There was no significant difference between the urban and rural children, but the children of non-manual workers had a significantly larger head than those of manual workers.
Assuntos
Cabeça/anatomia & histologia , Adolescente , Adulto , Criança , Pré-Escolar , Feminino , Humanos , Irlanda , Masculino , Classe Social , Reino Unido , População BrancaRESUMO
A cross-sectional study, measuring height and weight, was performed on a representative sample of 3,509 Irish children aged from 5 to 19 years inclusive. Comparison with other countries showed a significantly later pubertal growth spurt than either the U.K. or the U.S. However, the final adult height and weight are similar to other countries as in the weight-for-height of children aged 5 to 9 years. The urban children are taller than the rural and the higher socio-economic groups are taller than the lower at all ages, but all achieved the same final adult height. Longitudinal tempo-conditional growth standards were constructed based on the Irish cross-sectional and menarche data together with all the available information from longitudinal studies. These charts are similar to those of the U.K., but the use of colours allows more information to be put on the charts, thus making them more suitable for clinical use.
Assuntos
Crescimento , Adolescente , Adulto , Fatores Etários , Estatura , Peso Corporal , Criança , Desenvolvimento Infantil , Pré-Escolar , Estudos Transversais , Feminino , Humanos , Irlanda , Masculino , Valores de Referência , População Rural , Fatores Sexuais , Fatores Socioeconômicos , População UrbanaRESUMO
PIP: Age at menarche in Ireland is analyzed using data from a representative sample of 2,940 girls aged 9 to 17 drawn from schools in Dublin, Dundalk, Navan, and Portlaoise, of whom some half were urban and half rural residents. The mean age at menarche was 13.52 years. The authors note that this is the latest mean age at menarche recorded for a contemporary European population. No significant differences in age at menarche by place of residence or social class were noted.^ieng